These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3292811)

  • 41. [Nifedipine treatment of pulmonary hypertension as a complication of chronic obstructive diseases of the lungs].
    Paleev NR; Tsa'rkova LN; Uribe-Echevarria EE; Baklykova SN; Novoderezhkina LB
    Klin Med (Mosk); 1989 Jun; 67(6):117-20. PubMed ID: 2674536
    [No Abstract]   [Full Text] [Related]  

  • 42. Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.
    Brownlee JR; Beekman RH; Rosenthal A
    Pediatr Res; 1988 Aug; 24(2):186-90. PubMed ID: 3186330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hypoxic pulmonary hypertension: nifedipine therapy].
    Agostoni P; Doria E; Galli C; Tamborini G; Fiorentini C; Guazzi M
    Cardiologia; 1988 Oct; 33(10):961-9. PubMed ID: 3233606
    [No Abstract]   [Full Text] [Related]  

  • 44. Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension.
    Johnson CE; Beekman RH; Kostyshak DA; Nguyen T; Oh DM; Amidon GL
    Pediatr Res; 1991 May; 29(5):500-3. PubMed ID: 1896255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The pharmacokinetics of different drug forms of nifedipine when used singly and in a course as monotherapy and in combination with Cordanum and triampur preparations in patients with arterial hypertension].
    Kukes VG; Ignat'ev VG; Pavlov SS; Starodubtsev AK
    Eksp Klin Farmakol; 1995; 58(6):22-5. PubMed ID: 8704605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute and long term effect of nifedipine on pulmonary hypertension secondary to chronic obstructive airways disease.
    Johnson DC; Joshi RC; Mehta R; Cunnington AR
    Eur J Respir Dis Suppl; 1986; 146():495-502. PubMed ID: 3465575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Therapy of primary pulmonary arterial hypertension: current status].
    Solèr M
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1701-7. PubMed ID: 7939536
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative studies of hemodynamics under prostacyclin and nifedipine in patients with Eisenmenger syndrome].
    Gildein HP; Wildberg A; Mocellin R
    Z Kardiol; 1995 Jan; 84(1):55-63. PubMed ID: 7863716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
    McLaughlin VV; Genthner DE; Panella MM; Rich S
    N Engl J Med; 1998 Jan; 338(5):273-7. PubMed ID: 9445406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases].
    Lanzarini L; Gavazzi A; Mussini A; Graziano G; Campana C; Bargiggia G; Angoli L; Aimè E; Arbustini E; Montemartini C
    G Ital Cardiol; 1990 Feb; 20(2):114-22. PubMed ID: 2328864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension.
    Sadushi-Koliçi R; Skoro-Sajer N; Zimmer D; Bonderman D; Schemper M; Klepetko W; Glatz J; Jakowitsch J; Lang IM
    J Heart Lung Transplant; 2012 Jul; 31(7):735-43. PubMed ID: 22480725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B; Cheng YS; Dai DZ; Li N; Zhang TT; Dai Y
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):169-75. PubMed ID: 18986320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
    Nakayama T; Ishikita T; Matsuura H; Saji T
    J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pharmacologic effects of peripheral vasodilators in patients with secondary pulmonary hypertension].
    Kukes VG; Tsoĭ AN; Abrosimov AG; Nasyrov ShN; Belov AM
    Klin Med (Mosk); 1989 May; 67(5):52-6. PubMed ID: 2671486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A case of primary pulmonary hypertension with beneficial effect of oral long-acting prostaglandin E1 and nifedipine].
    Oida A; Ogawa K; Nagao I; Tsukada K; Yoshimura M
    Kokyu To Junkan; 1989 Nov; 37(11):1247-51. PubMed ID: 2602682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The comparative efficacy and prognosis of the long-term treatment with korinfar of men and women suffering from hypertension].
    Maslova NP; Baranova EI; Barabanova NG
    Ter Arkh; 1991; 63(8):52-5. PubMed ID: 1792619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of a combination therapy of anticoagulant and vasodilator on the long-term prognosis of primary pulmonary hypertension.
    Ogata M; Ohe M; Shirato K; Takishima T
    Jpn Circ J; 1993 Jan; 57(1):63-9. PubMed ID: 8437343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of large doses of nifedipine on pulmonary hypertension in patients with recurrent pulmonary thromboembolism].
    Pałasiewicz G; Tomkowski W; Hajduk B; Fijałkowska A; Radomyski A; Filipecki S; Polowiec Z
    Pneumonol Alergol Pol; 1994; 62(3-4):143-9. PubMed ID: 8061639
    [TBL] [Abstract][Full Text] [Related]  

  • 59. STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.
    Barst RJ; Beghetti M; Pulido T; Layton G; Konourina I; Zhang M; Ivy DD;
    Circulation; 2014 May; 129(19):1914-23. PubMed ID: 24637559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hemodynamic effects of aminophylline and nifedipine in patients with high altitude pulmonary edema].
    Mou XB; Li SZ; Gao YQ; Liou FY; Ye GL; Tang HY; Zhou XB; Cheng GL
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2004 Feb; 20(1):58-60. PubMed ID: 21162310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.